Format

Send to

Choose Destination
See comment in PubMed Commons below
J Affect Disord. 2014 Sep;166:193-200. doi: 10.1016/j.jad.2014.05.012. Epub 2014 May 22.

Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.

Author information

1
Dokuz Eylul University, Medical School, Izmir, Turkey. Electronic address: zeliha.tunca@deu.edu.tr.
2
Dokuz Eylul University, Medical School, Izmir, Turkey.
3
Celal Bayar University, Faculty of Medicine, Manisa, Turkey.

Abstract

OBJECTIVE:

Brain-derived neurotrophic factor (BDNF) has been consistently reported to be decreased in mania or depression in bipolar disorders. Evidence suggests that Glial cell line-derived neurotrophic factor (GDNF) has a role in the pathogenesis of mood disorders. Whether GDNF and BDNF act in the same way across different episodes in bipolar disorders is unclear.

METHOD:

BDNF and GDNF serum levels were measured simultaneously by enzyme-linked immunosorbent assay (ELISA) method in 96 patients diagnosed with bipolar disorder according to DSM-IV (37 euthymic, 33 manic, 26 depressed) in comparison to 61 healthy volunteers. SCID- I and SCID-non patient version were used for clinical evaluation of the patients and healthy volunteers respectively. Correlations between the two trophic factor levels, and medication dose, duration and serum levels of lithium or valproate were studied across different episodes of illness.

RESULTS:

Patients had significantly lower BDNF levels during mania and depression compared to euthymic patients and healthy controls. GDNF levels were not distinctive. However GDNF/BDNF ratio was higher in manic state compared to euthymia and healthy controls. Significant negative correlation was observed between BDNF and GDNF levels in euthymic patients. While BDNF levels correlated positively, GDNF levels correlated negatively with lithium levels. Regression analysis confirmed that lithium levels predicted only GDNF levels positively in mania, and negatively in euthymia.

LIMITATIONS:

Small sample size in different episodes and drug-free patients was the limitation of thestudy.

CONCLUSION:

Current data suggests that lithium exerts its therapeutic action by an inverse effect on BDNF and GDNF levels, possibly by up-regulating BDNF and down-regulating GDNF to achieve euthymia.

KEYWORDS:

BDNF (Brain-derived neurotrophic factor); Bipolar disorder; GDNF (glial cell line-derived neurotrophic factor); Lithium; Valproate

PMID:
25012431
DOI:
10.1016/j.jad.2014.05.012
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center